Press release | 17th July 2019

ActivityBase and ActivityBase XE Version 9.5 Released

The latest version of ActivityBase and ActivityBase XE version 9.5 has been released to customers. This forms part of IDBS’ regular bi-annual product release and continues our investment into ActivityBase, supporting our large top pharma and biotech customer base. 

Over the past few releases IDBS has added offerings to enable collaborations between pharma/biotech and CROs, reduced product complexity and improved workflow via a modern web experience, created server-side processing so data can be processed on the go, added new algorithms to correct data, and introduced methods to support new calculations.  

This release adds a mixture of new functionality and addresses key customer defects, with many of the updates informed by direct customer feedback. 

ActivityBase remains a core platform for early stage research for many of the world’s top R&D organizations. We will be increasing our investment in the product and will continue working with customers to ensure ActivityBase remains the world’s best and most established offering for high throughput and low volume screening. 

For more information on ActivityBase, click here. 

About IDBSContact us

More news

Webinar | November 30 | Managing the Journey from Process Development to Insight

In this session, you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how out-of-the box workflows and integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.

Read more

IDBS Polar Insight

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Read more

Skyland Analytics Acquisition

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.

Read more

IDBS Acquires Skyland Analytics

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.

Read more